chr12-49544030-A-G
Variant names:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The NM_012284.3(KCNH3):c.939A>G(p.Ala313Ala) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.187 in 1,613,434 control chromosomes in the GnomAD database, including 33,098 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.27 ( 7221 hom., cov: 33)
Exomes 𝑓: 0.18 ( 25877 hom. )
Consequence
KCNH3
NM_012284.3 synonymous
NM_012284.3 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -4.23
Genes affected
KCNH3 (HGNC:6252): (potassium voltage-gated channel subfamily H member 3) The protein encoded by this gene is a voltage-gated potassium channel alpha subunit predominantly expressed in the forebrain. Studies in mice have found that cognitive function increases when this gene is knocked out. In humans, the encoded protein has been shown to be capable of binding glycoprotein 120 of the human immunodeficiency virus type 1 (HIV-1) envelope. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Sep 2015]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.93).
BP6
Variant 12-49544030-A-G is Benign according to our data. Variant chr12-49544030-A-G is described in ClinVar as [Benign]. Clinvar id is 1290430.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-4.23 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.51 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
KCNH3 | NM_012284.3 | c.939A>G | p.Ala313Ala | synonymous_variant | Exon 6 of 15 | ENST00000257981.7 | NP_036416.1 | |
KCNH3 | NM_001314030.2 | c.759A>G | p.Ala253Ala | synonymous_variant | Exon 6 of 15 | NP_001300959.1 | ||
KCNH3 | XM_011538085.3 | c.939A>G | p.Ala313Ala | synonymous_variant | Exon 6 of 15 | XP_011536387.1 | ||
KCNH3 | XM_047428613.1 | c.939A>G | p.Ala313Ala | synonymous_variant | Exon 6 of 10 | XP_047284569.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.266 AC: 40511AN: 152038Hom.: 7179 Cov.: 33
GnomAD3 genomes
AF:
AC:
40511
AN:
152038
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.185 AC: 46522AN: 251438Hom.: 5444 AF XY: 0.180 AC XY: 24463AN XY: 135896
GnomAD3 exomes
AF:
AC:
46522
AN:
251438
Hom.:
AF XY:
AC XY:
24463
AN XY:
135896
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.179 AC: 261006AN: 1461278Hom.: 25877 Cov.: 42 AF XY: 0.177 AC XY: 128527AN XY: 726812
GnomAD4 exome
AF:
AC:
261006
AN:
1461278
Hom.:
Cov.:
42
AF XY:
AC XY:
128527
AN XY:
726812
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.267 AC: 40620AN: 152156Hom.: 7221 Cov.: 33 AF XY: 0.262 AC XY: 19525AN XY: 74398
GnomAD4 genome
AF:
AC:
40620
AN:
152156
Hom.:
Cov.:
33
AF XY:
AC XY:
19525
AN XY:
74398
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
635
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: not provided
- -
Apr 15, 2020
GeneDx
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at